News and views

Results from the REVEAL (Randomized Evaluation of the Effects of Anacetrapib through Lipid Modification) study show anacetrapib, an investigational cholesteryl ester transfer protein (CETP) inhibitor, lowers the risk of myocardial infarction and related cardiovascular complications in patients intensively treated with a statin....

The development of new potassium binding agents has increased interest in the field of hyperkalaemia management. This was the topic of a Vifor-sponsored satellite symposium at the meeting entitled ‘Enabling and optimising renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management’....

As one in every two heart failure patients has iron deficiency, an appropriate and timely question asked during the meeting was: “should iron be at the heart of our concerns?”...

Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late-breaking research presented at a hotline session and published simultaneously in the New England Journal of Medicine (https://doi.org/10.1056/NEJMoal1706222)....

Researchers are calling for a reconsideration of global dietary guidelines in light of new data presented at the Congress on fat intake and cardiovascular risk and mortality....

National audit shows improved heart failure survival...

‘Biological bypass’ shows promise in coronary artery disease...

Pitfalls in the interpretation of cardiopulmonary exercise testing data Dear Sirs Cardiopulmonary exercise testing (CPET) is non-invasive, safe,1 and reproducible.2 CPETs provide objective information on exercise capacity. Peak oxygen uptake (VO2 peak) – the primary parameter when investigating a decrease in exercise tolerance – is affected by many cardiac and non-cardiac diseases and is a validated independent predictor for hospitalisation and death.3–5 The oxygen uptake efficiency slope (OUES) is another valuable measurement to assess exercise tolerance and is valid even when patients are not able to exercise till their maximum. ...

The theme running through the recent 2017 British Cardiovascular Society (BCS) Annual Conference was ‘Cardiology at the extremes’. Few conditions in medicine can be more extreme than chronic and acute exacerbations of heart failure. In this report from the BCS meeting in Manchester, we focus on heart failure since it is 30 years since the landmark Co-operative North Scandinavian Enalapril Survival Study (CONSENSUS) was reported, a milestone noted at the conference. In accompanying podcasts, we interview some of the presenters who have been much involved in heart failure services in the UK to find out their experiences of the ‘real world’ of managing heart failure outside randomised clinical trials and also consider what challenges remain in this field. ...

Air pollution linked to heart problems...